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For HIV infection to take hold, a virus particle must ﬁ  rst 
attach to a cell to gain entry. Once inside, the viral genome is 
reverse transcribed from RNA to DNA, and then integrated 
into the host genome. By co-opting the host’s molecular 
machinery, the virus churns out multiple copies of its genome 
(transcribed back into RNA), and viral components are 
synthesized and assembled into particles that leave the cell 
and begin the cycle anew. Viral assembly is mediated by the 
virus’s major structural protein, Gag, which can be fused to 
another viral protein, Pol, which encodes the virus’s enzymes.
In the traditional model, Gag proteins assemble at the 
plasma membrane prior to release. Multiple studies have 
recently challenged this model, however, showing abundant 
Gag proteins and mature virions in structures called 
endosomes, which take up extracellular molecules and 
particles through a process called endocytosis. These studies 
proposed that Gag is ﬁ  rst sent to endosomal membranes 
before reaching the plasma membrane or extracellular space 
through an endosome-based transport pathway. 
Initial studies described this endosomal assembly pathway 
as unique to macrophages, the primary targets of HIV 
infection, though other studies have suggested it may occur 
in all cell types. In a new study, Nolwenn Jouvenet, Paul 
Bieniasz, and their colleagues combined pharmacological, 
genetic, biochemical, and microscopic approaches to 
determine where HIV assembles in the cell. Their results 
undercut several elements of the endosomal model and place 
the traditional model back on a solid foundation.
To track HIV Gag localization and assembly, the authors 
started by transiently inducing Gag protein expression in a 
standard experimental cell line (293T cells). About 10 hours 
after transfecting cells with the Gag gene, they detected Gag-
Pol processing, an indicator of assembly, and particle release. 
If Gag targeting to endosomes initiates particle assembly or 
transport to the membrane, the authors reasoned, then both 
processes should depend on endosome motility. But when cells 
were treated with a drug that blocks endosome movement, HIV 
assembly was unaffected, based on Gag processing and particle 
release. Further, microscopic analysis showed high levels of 
ﬂ  uorescently tagged Gag proteins at the plasma membrane. 
Thus, they concluded, neither Gag transport to the plasma 
membrane nor virion assembly relied on endosome motility. 
Fluorescently tagged Gag proteins were seen either 
scattered throughout the cytoplasm, assembled at the 
plasma membrane (about 4 hours after transfection), or 
accumulating both in internal compartments and at the 
plasma membrane (8–10 hours after transfection). The 
internal compartments turned out to be endosomes (based 
on characteristic protein markers), and the authors suspected 
that their accumulated Gag contents had been acquired 
through endocytosis; when they used genetic tools to block 
endocytosis, the endosomal Gag accumulations were no 
longer evident. What’s more, inhibiting endosomal Gag had 
no effect on virion assembly and release.
The authors also manipulated Gag’s membrane-binding 
domain to assess the consequences on viral assembly and 
release. If Gag is initially sent to endosomes to trigger HIV 
assembly and release, then exchanging Gag’s membrane-
binding protein with a domain that targets endosomes 
should precipitate particle assembly and release. But that’s 
not what the authors found. Gag and Pol proteins that were 
artiﬁ  cially targeted to the plasma membrane triggered virion 
assembly and release just as efﬁ  ciently as their wild-type 
(nonmanipulated) counterparts, but direct targeting of 
Gag proteins to endosomes resulted in particle assembly in 
endosomes but little or no particle release.
The authors repeated these experiments in macrophages, 
one of the virus’s natural targets, using a new technique that 
facilitates transfection in macrophages. Localization patterns 
of newly synthesized Gag proteins followed a temporal 
pattern similar to that seen in the 293T cells. Just 4–6 hours 
after transfection, ﬂ  uorescently tagged Gag proteins were 
either distributed throughout the cytoplasm or clustered 
at the plasma membrane. At 24 hours, Gag was also seen in 
internal compartments. And similar to what was found in 
293T cells, inhibiting endosomal transport in macrophages 
revealed that endosomes cannot support virion assembly and 
release in these cells either.
Altogether, these results reafﬁ  rm the long-established 
model that Gag-mediated particle assembly occurs at the 
plasma membrane. Virions seen in endosomes arrive there 
through an endocytic pathway at a later point, which does 
not support HIV release. In fact, the authors argue, assuming 
a slow rate of Gag synthesis and a high rate of plasma 
membrane internalization, one would expect most HIV Gag 
particles to wind up in endosomes. Future studies can further 
explore the kinetics that determine the rate at which virions 
are released or sequestered in cellular compartments. But the 
authors argue that their results unequivocally demonstrate 
that HIV assembly occurs at the plasma membrane.
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HIV-1 particles assembling at the surface of an infected 
macrophage.